CCAAT enhancer-binding protein-α (C/EBPα) is another tumor suppressor that can inhibit cell proliferation [11,12], and mutations in CEBPA are widely reported in acute myeloid leukemia (AML) patients [13-16]. Here, CEBPA is linked to neoplasm.